Anna E. Marneth

Nijmegen, GE 6500HB, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Comprehensive lincRNA Transcriptome in Acute Myeloid Leukemia: Integrating Known and Newly Identified lincRNAs Across Pediatric and Adult Cohorts.

Comprehensive lincRNA Transcriptome in Acute Myeloid Leukemia: Integrating Known and Newly Identified lincRNAs Across Pediatric and Adult Cohorts.

Journal: Non-coding RNA
Published: April 17, 2026

Sialic acid cis-ligand dynamics modulate Siglec-7 and -9 function and affect Siglec-7/9 co-blockade to potentiate natural killer cell anti-tumor activity.

Sialic acid cis-ligand dynamics modulate Siglec-7 and -9 function and affect Siglec-7/9 co-blockade to potentiate natural killer cell anti-tumor activity.

Journal: Oncoimmunology
Published: April 03, 2026

Risk stratification of patients with TP53-mutated myeloproliferative neoplasms.

Risk stratification of patients with TP53-mutated myeloproliferative neoplasms.

Journal: Leukemia
Published: September 02, 2025

Mutant SRSF2-associated impaired erythropoiesis is defined by increased mTORC1 signaling due to FYN missplicing.

Mutant SRSF2-associated impaired erythropoiesis is defined by increased mTORC1 signaling due to FYN missplicing.

Journal: Leukemia
Published: May 12, 2025

ZRSR2 loss causes aberrant splicing in JAK2V617F-driven myeloproliferative neoplasm but is not sufficient to drive disease progression.

ZRSR2 loss causes aberrant splicing in JAK2V617F-driven myeloproliferative neoplasm but is not sufficient to drive disease progression.

Journal: HemaSphere
Published: February 13, 2025

Cardiovascular risk factors in myeloproliferative neoplasms: associations with survival and thrombotic outcomes.

Cardiovascular risk factors in myeloproliferative neoplasms: associations with survival and thrombotic outcomes.

Journal: Blood vessels, thrombosis & hemostasis
Published: August 16, 2024

Risk of bleeding in patients with essential thrombocythemia and extreme thrombocytosis.

Risk of bleeding in patients with essential thrombocythemia and extreme thrombocytosis.

Journal: Blood advances
Published: May 28, 2024

Editorial: Transcriptional and epigenetic regulation in normal and aberrant hematopoiesis.

Editorial: Transcriptional and epigenetic regulation in normal and aberrant hematopoiesis.

Journal: Frontiers in molecular biosciences
Published: February 20, 2024

Mesenchymal Stromal Cells Facilitate Neutrophil-Trained Immunity by Reprogramming Hematopoietic Stem Cells.

Mesenchymal Stromal Cells Facilitate Neutrophil-Trained Immunity by Reprogramming Hematopoietic Stem Cells.

Journal: Journal of innate immunity
Published: September 21, 2022

CALR-mutated cells are vulnerable to combined inhibition of the proteasome and the endoplasmic reticulum stress response.

CALR-mutated cells are vulnerable to combined inhibition of the proteasome and the endoplasmic reticulum stress response.

Journal: Leukemia
Published: June 16, 2022

Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine.

Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine.

Journal: Science translational medicine
Published: June 15, 2022

Whole-genome CRISPR screening identifies N-glycosylation as a genetic and therapeutic vulnerability in CALR-mutant MPNs.

Whole-genome CRISPR screening identifies N-glycosylation as a genetic and therapeutic vulnerability in CALR-mutant MPNs.

Journal: Blood
Published: January 21, 2022
Showing 1-12 of 26

Last Updated: 09/26/2026